1-20 of 29
S Singhal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Relationship Between Serum Free Light Chain Levels and Urine Protein in Patients with IgG or IgA Myeloma.

J. Mehta, E. Vickrey, D. Ramadurai, E. Voigt, C. Fitzpatrick, S. Singhal
Journal: Blood
Blood (2009) 114 (22): 1810.
https://doi.org/10.1182/blood.V114.22.1810.1810
Published: 2009
Journal Articles

Cytomegalovirus Seropositivity Does Not Affect the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation with Intensive Monitoring and Modern Anti-Viral Therapy

S. Singhal, Rucha Mehta, J. Krishnamurthy, S. Duffey, O. Frankfurt, Andrew M Evens, DO, MS, J. Altman, M. Tallman, L. Gordon, S. Williams, J. Winter, J. Mehta
Journal: Blood
Blood (2008) 112 (11): 4370.
https://doi.org/10.1182/blood.V112.11.4370.4370
Published: 2008
Journal Articles

Actual (ABW) or Ideal (IBW) Body Weight to Calculate CD34+ Cell Dose in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Myeloma?

J. Krishnamurthy, V. Singh, O. Frankfurt, Andrew M Evens, DO, MS, J. Altman, L. Gordon, S. Singhal, M. Tallman, S. Williams, J. Winter, J. Mehta
Journal: Blood
Blood (2008) 112 (11): 4455.
https://doi.org/10.1182/blood.V112.11.4455.4455
Published: 2008
Journal Articles

Factors Affecting the Results of Allogeneic Hematopoietic Stem Cell Transplantation in Hematologic Malignancies

J. Mehta, O. Frankfurt, J. Altman, Andrew M Evens, DO, MS, L. Gordon, M. Tallman, S. Williams, J. Winter, J. Krishnamurthy, D. Grinblatt, L. Kaminer, S. Singhal
Journal: Blood
Blood (2008) 112 (11): 4386.
https://doi.org/10.1182/blood.V112.11.4386.4386
Published: 2008
Journal Articles

The Influence of Disease-Specific Prognostic Factors on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Myeloma

S. Singhal, E. Vickrey, S. Allen, J. Krishnamurthy, S. Duffey, S. Williams, J. Mehta
Journal: Blood
Blood (2008) 112 (11): 4395.
https://doi.org/10.1182/blood.V112.11.4395.4395
Published: 2008
Journal Articles

The Relationship Between Serum Free Light Chain Levels and Serum Immunofixation Electrophoresis: Implications for the Definition of “Stringent CR” in Myeloma

S. Allen, E. Vickrey, J. Mehta, S. Singhal
Journal: Blood
Blood (2008) 112 (11): 2724.
https://doi.org/10.1182/blood.V112.11.2724.2724
Published: 2008
Journal Articles

The Effect of Increasing CD34+ Cell Doses on Time to Engraftment after Autotransplantation for Hematologic Malignancies.

V. Singh, J. Krishnamurthy, O. Frankfurt, Andrew M Evens, DO, MS, J. Altman, L. Gordon, S. Singhal, M. Tallman, S. Williams, J. Winter, J. Mehta
Journal: Blood
Blood (2008) 112 (11): 1115.
https://doi.org/10.1182/blood.V112.11.1115.1115
Published: 2008
Journal Articles

Optimizing the CD34+ Cell Dose for Allogeneic Transplantation.

J. Mehta, Andrew M Evens, DO, MS, J. Altman, O. Frankfurt, Martin Tallman, MD, L. Gordon, S. Williams, J. Winter, J. Krishnamurthy, S. Duffey, V. Singh, R. Meagher, S. Singhal
Journal: Blood
Blood (2008) 112 (11): 1118.
https://doi.org/10.1182/blood.V112.11.1118.1118
Published: 2008
Journal Articles

The Hematopoietic Cell Transplantation Comorbidity Index: No Effect on Outcome of Reduced-Intensity Allografts.

O. Frankfurt, J. Altman, J. Krishnamurthy, Andrew M Evens, DO, MS, L. Gordon, S. Singhal, M. Tallman, S. Williams, J. Winter, S. Duffey, V. Singh, R. Meagher, J. Mehta
Journal: Blood
Blood (2008) 112 (11): 1119.
https://doi.org/10.1182/blood.V112.11.1119.1119
Published: 2008
Journal Articles

The Utility of Serum Free Light Chain Measurement in Myeloma Patients with Oligoclonal Bands on Serum or Urine Immunofixation

E. Vickrey, S. Allen, J. Krishnamurthy, V. Singh, J. Mehta, S. Singhal
Journal: Blood
Blood (2008) 112 (11): 5121.
https://doi.org/10.1182/blood.V112.11.5121.5121
Published: 2008
Journal Articles

Multi-Center Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Promising Activity as Combination Therapy with Manageable Toxicity.

Paul Richardson, S. Lonial, A. Jakubowiak, A. Krishnan, J. Wolf, J. Densmore, S. Singhal, I. Ghobrial, J. Stephenson, J. Mehta, K. Colson, D. Francis, T. Kendall, N. Obadike, K. Sullivan, J. Martin, T. Hideshima, L. Lai, P. Sportelli, L. Gardner, R. Birch, I.C. Henderson, K. Anderson
Journal: Blood
Blood (2007) 110 (11): 1164.
https://doi.org/10.1182/blood.V110.11.1164.1164
Published: 2007
Journal Articles

A Multicenter Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (Dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM).

Paul Richardson, S. Lonial, A. Jakubowiak, J. Wolf, A. Krishnan, J. Densmore, S. Singhal, I. Ghobrial, L. Schwartzberg, K. Colson, J. Harris, T. Kendall, B. Martineau, N. Obadike, K. Sullivan, S. Pearson, T. Hideshima, L. Lai, P. Sportelli, L. Gardner, R. Birch, I.C. Henderson, K.C. Anderson
Journal: Blood
Blood (2006) 108 (11): 3582.
https://doi.org/10.1182/blood.V108.11.3582.3582
Published: 2006
Journal Articles

Oral Busulfan and Cyclophosphamide or IV Busulfan and Fludarabine for Allogeneic HSCT in Hematologic Malignancies?.

J. Altman, N. Venepalli, J. Monreal, K. Rashid, L. Gordon, J. Winter, S. Williams, M. Tallman, O. Frankfurt, A. Evens, S. Singhal, J. Mehta
Journal: Blood
Blood (2006) 108 (11): 2940.
https://doi.org/10.1182/blood.V108.11.2940.2940
Published: 2006
Journal Articles

Outcome of Submyeloablative Allogeneic HSCT for Hematologic Malignancies: Development of a Prognostic Model Based on Pre-Transplant Characteristics.

Jayesh Mehta, A. Evens, O. Frankfurt, L. Gordon, D. Grinblatt, L. Kaminer, R. Meagher, M. Tallman, S. Williams, J. Winter, S. Singhal
Journal: Blood
Blood (2005) 106 (11): 1145.
https://doi.org/10.1182/blood.V106.11.1145.1145
Published: 2005
Journal Articles

The Effect of the Platelet Content of Blood Stem Cell Grafts on GVHD.

Jayesh Mehta, R. Meagher, A. Evens, O. Frankfurt, S. Singhal, M. Tallman, S. Williams, J. Winter, D. Grinblatt, L. Kaminer, L. Gordon
Journal: Blood
Blood (2005) 106 (11): 1077.
https://doi.org/10.1182/blood.V106.11.1077.1077
Published: 2005
Journal Articles

Identifying Patients at Risk of Early Relapse after Submyeloablative Allogeneic HSCT.

Jayesh Mehta, L. Gordon, M. Tallman, J. Winter, S. Williams, A. Evens, O. Frankfurt, D. Grinblatt, L. Kaminer, R. Meagher, S. Singhal
Journal: Blood
Blood (2005) 106 (11): 5390.
https://doi.org/10.1182/blood.V106.11.5390.5390
Published: 2005
Journal Articles

Low-Dose Recombinante Urate Oxidase (Rasburicase) Is Effective in Treating Hyperuricemia in Patients with Hematologic Malignancies.

S. Trifilio, A. Evens, L. Gordon, S. Singhal, M. Tallman, J. Mehta
Journal: Blood
Blood (2005) 106 (11): 3123.
https://doi.org/10.1182/blood.V106.11.3123.3123
Published: 2005
Journal Articles

Safety and Efficacy of Bortezomib in Multiple Myeloma Patients with Renal Failure Requiring Dialysis.

Asher Alban Chanan-Khan, P. Richardson, S. Lonial, D. Siegel, S. Jagannath, J. Mehta, J. Doran, S. Singhal
Journal: Blood
Blood (2005) 106 (11): 2550.
https://doi.org/10.1182/blood.V106.11.2550.2550
Published: 2005
Journal Articles

Pre-Transplant Variables Affecting the Outcome of Submyeloablative Allogeneic HSCT in Uniformly Treated Patients with Hematologic Malignancies.

Jayesh Mehta, S. Singhal, M. Tallman, S. Williams, J. Winter, A. Evens, D. Grinblatt, L. Kaminer, L. Gordon
Journal: Blood
Blood (2004) 104 (11): 2324.
https://doi.org/10.1182/blood.V104.11.2324.2324
Published: 2004
Journal Articles

Is a Younger 10-Allele-Matched Unrelated Donor (MUD) Better Than an Older 6-Antigen-Matched Sibling Donor (MSD) for Allogeneic HSCT?.

Jayesh Mehta, L. Gordon, M. Tallman, J. Winter, S. Williams, A. Evens, D. Grinblatt, L. Kaminer, S. Singhal
Journal: Blood
Blood (2004) 104 (11): 2757.
https://doi.org/10.1182/blood.V104.11.2757.2757
Published: 2004